A State of Revision
In an effort to make the monograph creation and revision process more efficient, the United States Pharmacopeia-National Formulary's Prescription-Non-Prescription Stakeholders Forum created a number of project teams in 2000, several of which were directed to provide recommendations about the co...
Gespeichert in:
Veröffentlicht in: | Pharmaceutical Technology 2003-12, Vol.27 (12), p.72 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In an effort to make the monograph creation and revision process more efficient, the United States Pharmacopeia-National Formulary's Prescription-Non-Prescription Stakeholders Forum created a number of project teams in 2000, several of which were directed to provide recommendations about the content and presentation of drug substance monographs. The Non-Complex Actives Drug Substance, Complex Actives, and Excipient Project Teams contributed to the creation of a guideline to aid parties who were interested in submitting requests for revisions to USP-NF. After multiple iterations and as a result of noteworthy collaborative efforts involving USP's core staff and members of USP's Council of Experts, USP recently released its "USP Guideline for Submitting Requests for Revision to the USP-NF". This 75-page document provides helpful information about submitting new monographs and revising existing monographs for noncomplex substances and products, biological and biotechnology substances and products, excipients, and vaccines. |
---|---|
ISSN: | 1543-2521 2150-7376 |